[Long-term development in treated cervical dysplasias].
The study of 324 cervical dysplasia treated and followed from 1 to 15 years allows to draw three major risks from conservative treatment: micro invasions or invasions, non seen at diagnosis time; risk of residual lesion whatever the used treatment; risk of recurrence from 7 months to 7 years after the last treatment. The ratio of cure (actuarial analysis) is about 92% at 3 years and 88% at 6 years. Whatever the patient's age, the lesion's degree or the treatment used, the risk of recurrence can be fixed up to 6.17%. Only the concordance of diagnostical means and the long term follow up should decrease consequences of medical therapeutic failures.
Clinique de Gynécologie-Obstétrique et Pathologie de la reproduction, Université de Lille II.
M
M
Delecour
D002278:Carcinoma in Situ / Q000175:diagnosis; D005260:Female; D006801:Humans; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D013997:Time Factors; D017211:Treatment Failure; D002578:Uterine Cervical Dysplasia / Q000473:pathology / Q000628:therapy*
Evolution à long terme des dysplasies cervicales traitées.